Oxidative stress and eicosanoids in the kidneys of hyperglycemic rats treated with dehydroepiandrosterone

被引:31
作者
Aragno, M
Parola, S
Brignardello, E
Manti, R
Betteto, S
Tamagno, E
Danni, O
Boccuzzi, G
机构
[1] Univ Turin, Dept Clin Pathophysiol, I-10126 Turin, Italy
[2] Univ Turin, Dept Expt Med & Oncol, Gen Pathol Sect, I-10126 Turin, Italy
关键词
hydroperoxyeicosatetraenoic acid; hydroxynonenal; oxidative stress; polyol pathway; diabetes; dehydroepiandrosterone; Na/K-ATPase; free radicals;
D O I
10.1016/S0891-5849(01)00669-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress plays a crucial role in the pathogenesis of chronic diabetic complications. Normoglycemic and streptozotocin-diabetic rats were treated with dehydroepiandrosterone (DHEA) (4 mg/d per rat) for 3 weeks. At the end of treatment, hydroxynonenal, hydroperoxyeicosatetraenoic acids and antioxidant levels, as well as Na/K-ATPase activity and membrane fatty acids composition were evaluated in kidney homogenates. Chronic hyperglycemia caused a marked increase of both hydroxynonenal and lipoxygenase pathway products and a drop in both GSH levels and membrane Na/K-ATPase activity. DHEA treatment restored the antioxidant levels to close to the control value and considerably reduced hydroxynonenal and hydroperoxyeicosatetraenoic acid levels. Moreover, DHEA counteracted the detrimental effect of hyperglycemia on membrane function: the drop of Na/K-ATPase activity in diabetic animals was significantly inhibited by DHEA treatment. These results show that DHEA reduces oxidative stress and the consequent increase of lipoxygenase pathway products induced by experimental diabetes in rat kidney; they also suggest that, by reducing the inflammatory response to oxidative stress, DHEA treatment might delay the progression of diabetic kidney disease. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:935 / 942
页数:8
相关论文
共 67 条
[21]   Antioxidants, NFκB activation, and diabetogenesis [J].
Ho, E ;
Bray, TM .
PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (03) :205-213
[22]   ARACHIDONIC-ACID DEFICIENCY IN STREPTOZOTOCIN-INDUCED DIABETES [J].
HOLMAN, RT ;
JOHNSON, SB ;
GERRARD, JM ;
MAUER, SM ;
KUPCHOSANDBERG, S ;
BROWN, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (08) :2375-2379
[23]   Hemolytic effects of dehydroepiandrosterone in vitro [J].
Hu, ML ;
Ng, HP ;
Shih, MK .
LIFE SCIENCES, 1997, 61 (21) :2137-2142
[24]  
JIM K, 1982, J BIOL CHEM, V257, P294
[25]  
Keller JN, 1997, J NEUROCHEM, V69, P273
[26]  
Khalil A, 2000, J LIPID RES, V41, P1552
[27]   ENHANCEMENT OF ATPASE ACTIVITY BY A LIPID PEROXIDE OF ARACHIDONIC-ACID IN RAT-BRAIN MICROVESSELS [J].
KOIDE, T ;
ASANO, T ;
MATSUSHITA, H ;
TAKAKURA, K .
JOURNAL OF NEUROCHEMISTRY, 1986, 46 (01) :235-242
[28]  
LEISSING N, 1982, METHOD ENZYMOL, V89, P135
[29]   The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy [J].
Low, PA ;
Nickander, KK ;
Tritschler, HJ .
DIABETES, 1997, 46 :S38-S42
[30]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265